
|Articles|September 30, 2014
Segment 6 - Including Patient-Reported Outcomes
Although there are some efforts to marry progression-free survival benefits to clinical benefits defined by the patients, the approach is still in the early stages and needs to be moved forward more quickly, according to Michael Kolodziej, MD.
Advertisement
Although there are some efforts to marry progression-free survival benefits to clinical benefits defined by the patients, the approach is still in the early stages and needs to be moved forward more quickly, according to Michael Kolodziej, MD.
Kimberley Shafer-Weaver, PhD, agrees that the approach is still too much in its infancy to really be considered. Just because a patient is still alive does not mean they are feeling better and ready to go back to the workplace.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Timeline for 100% Generic Drug Tariffs Beginning in 2028, 200% in 2029
2
FDA Advisory Panel Weighs Access to 7 Popular Peptides This Week
3
Eplontersen Misses Primary End Point in Phase 3 ATTR-CM Cardiovascular Outcomes Trial
4
Impact of Automated Insulin Delivery on Type 2 Diabetes Measures
5




